{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:55:56Z","timestamp":1792756556482,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to develop and validate a non-invasive predictive model, which was a reliable nomogram to accurately differentiate AFPN-HCC from other intrahepatic malignant lesions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study enrolled 165 patients with malignant focal liver lesions, including AFPN-HCC (n=85) and other intrahepatic malignant lesions (n=80). Data were analyzed to screen for risk factors phase by using LASSO regression as well as univariate and multivariate logistic regression analysis. We constructed a model and developed a nomogram. Then using the area under the curve, Hosmer-Lemeshow test, calibration curves, decision curve analysis, and 1,000 bootstraps to assess and internally validate the model performance. We calculated the optimal threshold, sensitivity, specificity, positive and negative predictive value, and accuracy of the prediction model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>LASSO and multivariate logistic regression analyses indicated that tumor number, necrosis in tumor, arterial phase enhancement pattern, arterial phase perfusion velocity, and Kupffer phase degree of washout were the significant predictors to differentiate AFPN-HCC from OM. The AUC was 0.886, and the AUC of internal validation was 0.865. The optimal critical value of the predicted value was 0.524, with a sensitivity of 82.35%, specificity of 85.00%, positive predicted value of 85.37%, negative predicted value of 81.93%, and an accuracy of 83.64%. The <jats:italic>P<\/jats:italic> value of the Hosmer-Lemeshow test was 0.592. The calibration plots showed a high concordance of prediction. The decision curve analysis showed excellent net benefits.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our nomogram has excellent discrimination, calibration and clinical utility by combining SCEUS and clinical features, which may help clinicians improve the diagnostic performance for AFPN-HCC, contributing to individualized treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1623670","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T13:01:21Z","timestamp":1752757281000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Differentiation of AFP-negative hepatocellular carcinoma from other intrahepatic malignant lesions by a noninvasive predictive model based on Sonazoid contrast-enhanced ultrasound"],"prefix":"10.3389","volume":"15","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.2183","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4530","article-title":"The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00443.x","article-title":"Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither","volume":"101","author":"Farinati","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12010141","article-title":"Noninvasive diagnosis of hepatocellular carcinoma on sonazoid-enhanced US: value of the kupffer phase","volume":"12","author":"Takahashi","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2020.04.030","article-title":"Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS","volume":"46","author":"Dietrich","year":"2020","journal-title":"Ultrasound Med Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PloS Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2023.02.015","article-title":"Prediction of microvascular invasion in solitary AFP-negative hepatocellular carcinoma \u2264 5 cm using a combination of imaging features and quantitative dual-layer spectral-detector CT parameters","author":"Zhu","year":"2023","journal-title":"Acad Radiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12880-024-01206-7","article-title":"Preoperative evaluation of microvascular invasion in hepatocellular carcinoma with a radiological feature-based nomogram: a bi-center study","volume":"24","author":"Deng","year":"2024","journal-title":"BMC Med Imaging"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25046","article-title":"New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection","volume":"117","author":"Gan","year":"2018","journal-title":"J Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2023.0324","article-title":"Diagnosing hepatocellular carcinoma using sonazoid contrast-enhanced ultrasonography: 2023 guidelines from the korean society of radiology and the korean society of abdominal radiology","volume":"24","author":"Jeong","year":"2023","journal-title":"Korean J Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.111060","article-title":"A review of contrast-enhanced ultrasound using SonoVue\u00ae and Sonazoid\u2122 in non-hepatic organs","volume":"167","author":"Zhang","year":"2023","journal-title":"Eur J Radiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.17998\/jlc.2023.08.25","article-title":"Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review","volume":"23","author":"Jeong","year":"2023","journal-title":"J Liver Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13244-024-01743-3","article-title":"Prediction of microvascular invasion in hepatocellular carcinoma with conventional ultrasound, Sonazoid-enhanced ultrasound, and biochemical indicator: a multicenter study","volume":"15","author":"Lu","year":"2024","journal-title":"Insights Imaging"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.14366\/usg.20120","article-title":"Sonazoid-enhanced ultrasonography: comparison with CT\/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma","volume":"40","author":"Hwang","year":"2021","journal-title":"Ultrasonography"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1109\/TMI.2017.2659734","article-title":"Computer-aided diagnosis of focal liver lesions using contrast-enhanced ultrasonography with perflubutane microbubbles","volume":"36","author":"Kondo","year":"2017","journal-title":"IEEE Trans Med Imaging"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-5152-x","article-title":"Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis","volume":"28","author":"Wu","year":"2018","journal-title":"Eur Radiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0859-1","article-title":"Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI","volume":"49","author":"Ohama","year":"2014","journal-title":"J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7863\/jum.2012.31.4.529","article-title":"Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading","volume":"31","author":"Sugimoto","year":"2012","journal-title":"J Ultrasound Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-023-03993-z","article-title":"Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study","volume":"48","author":"Wang","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11122250","article-title":"Diagnostic value of CEUS LI-RADS version 2017 in differentiating AFP-negative hepatocellular carcinoma from other primary Malignancies of the liver","volume":"11","author":"Wang","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-09339-5","article-title":"HCC treated with immune checkpoint inhibitors: a hyper-enhanced rim on Sonazoid-CEUS Kupffer phase images is a predictor of tumor response","volume":"33","author":"Huang","year":"2023","journal-title":"Eur Radiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14420","article-title":"Liver imaging reporting and data system category M: A systematic review and meta-analysis","volume":"40","author":"Kim","year":"2020","journal-title":"Liver Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010164","article-title":"Differentiating liver metastases from primary liver cancer: A retrospective study of imaging and pathological features in patients with histopathological confirmation","volume":"13","author":"Ghenciu","year":"2025","journal-title":"Biomedicines"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i36.5180","article-title":"Liver metastases: The role of magnetic resonance imaging","volume":"29","author":"Maino","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1148\/rg.220056","article-title":"Liver metastases: correlation between imaging features and pathomolecular environments","volume":"42","author":"Ozaki","year":"2022","journal-title":"Radiographics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.22.27521","article-title":"Contrast-enhanced ultrasound using perfluorobutane: impact of proposed modified LI-RADS criteria on hepatocellular carcinoma detection","volume":"219","author":"Li","year":"2022","journal-title":"AJR Am J Roentgenol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1623670\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T13:01:21Z","timestamp":1752757281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1623670\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":28,"alternative-id":["10.3389\/fonc.2025.1623670"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1623670","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"article-number":"1623670"}}